U.S. markets closed
  • S&P 500

    3,870.29
    -31.53 (-0.81%)
     
  • Dow 30

    31,391.52
    -143.99 (-0.46%)
     
  • Nasdaq

    13,358.79
    -230.04 (-1.69%)
     
  • Russell 2000

    2,231.51
    -43.81 (-1.93%)
     
  • Crude Oil

    59.47
    -1.17 (-1.93%)
     
  • Gold

    1,737.80
    +14.80 (+0.86%)
     
  • Silver

    26.87
    +0.19 (+0.72%)
     
  • EUR/USD

    1.2092
    +0.0032 (+0.27%)
     
  • 10-Yr Bond

    1.4150
    -0.0310 (-2.14%)
     
  • GBP/USD

    1.3963
    +0.0042 (+0.30%)
     
  • USD/JPY

    106.6710
    -0.0590 (-0.06%)
     
  • BTC-USD

    47,538.72
    -1,030.15 (-2.12%)
     
  • CMC Crypto 200

    949.74
    -36.91 (-3.74%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

Neuronetics: 1Q Earnings Snapshot

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

MALVERN, Pa. (AP) _ Neuronetics Inc. (STIM) on Tuesday reported a loss of $7.5 million in its first quarter.

On a per-share basis, the Malvern, Pennsylvania-based company said it had a loss of 42 cents.

The medical device company focused on psychiatric disorders posted revenue of $12.7 million in the period.

For the current quarter ending in July, Neuronetics said it expects revenue in the range of $15.6 million to $16.2 million.

The company expects full-year revenue in the range of $62.5 million to $64.5 million.

Neuronetics shares have declined 11% since the beginning of the year.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on STIM at https://www.zacks.com/ap/STIM